5 mg
CoA on request
Metabolic Research
Semaglutide
Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.
$129
View
5 mg - Research material
Metabolic Research
Retatrutide
Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.
Research price
$179
5 mg vial - Lyophilized powder
Research Use Only. This material is not for human consumption, injection, clinical use, or veterinary administration. Sold only to qualified researchers and institutions.
RUO policy.
Specifications
| Size | 5 mg |
|---|---|
| Form | Lyophilized powder |
| Purity / documentation | Lot-specific Certificate of Analysis available on request |
| CAS | 2381089-83-2 |
| Molecular weight | Approx. 4731 g/mol (reference; confirm lot CoA) |
| Sequence / identity | Triple agonist research peptide (GLP-1 / GIP / glucagon pathway literature) |
| Intended use | In vitro laboratory research only (RUO) |
Research context
Retatrutide research material is intended for qualified laboratory use studying multi-receptor metabolic pathways described in the scientific literature. Strictly research use only - not for human use.
Research focus areas
Triple agonist research
Metabolic pathway models
Preclinical literature compound
Content is for scientific reference only and does not constitute medical advice or instructions for human use.
Related research materials
5 mg
CoA on request
Metabolic Research
Tirzepatide
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
$149
View